Hot Features
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clin... OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.071 | -15.1063829787 | 0.47 | 0.47 | 0.3873 | 1424564 | 0.41956547 | CS |
| 4 | -0.2438 | -37.9278158058 | 0.6428 | 0.6678 | 0.3873 | 1451343 | 0.51786308 | CS |
| 12 | -0.1113 | -21.8106995885 | 0.5103 | 0.9 | 0.3873 | 6888589 | 0.66119253 | CS |
| 26 | -0.33 | -45.2674897119 | 0.729 | 0.9 | 0.3803 | 3899868 | 0.66274241 | CS |
| 52 | -1.001 | -71.5 | 1.4 | 1.79 | 0.3803 | 4373489 | 0.73533998 | CS |
| 156 | -3.861 | -90.6338028169 | 4.26 | 6.95 | 0.3803 | 4056840 | 1.15494078 | CS |
| 260 | -3.861 | -90.6338028169 | 4.26 | 6.95 | 0.3803 | 4056840 | 1.15494078 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.